AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $45.11
- 52-wk high
- $105.65
- High
- $46.27
- 52-wk low
- $42.20
- Low
- $44.89
- Prev close
- $44.98
- Mkt cap
- $65.16B
- P/E
- 18.2x
- Volume
- 17.98M
- Fwd P/E
- 13.2x
- Beta
- 0.57
- P/S
- 3.1x
- P/B
- 2.6x
- Profit margin
- +17.5%
- Op margin
- +22.9%
- ROE
- +15.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 3.6% above what analysts expected.
Earnings per share
$0.83 expected
Revenue
No comparable estimate
Reports Oct 28, 2026, in 48 days
EPS expected
$0.80 to $0.84
Revenue expected
24 analysts
Last 30 days
Analysts cutting estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.07B | $5.29B | $5.20B | $5.44B |
| Cost of what it sold | $1.52B | $1.35B | $1.59B | $1.59B |
| Gross profit | $3.54B | $3.94B | $3.61B | $3.85B |
| What it spent | ||||
| Research and development | $514.0M | $569.0M | $516.0M | $554.0M |
| Sales and admin | $1.74B | $1.83B | $1.78B | $1.80B |
| Other operating costs | $237.0M | $328.0M | $244.0M | $313.0M |
| Total operating expenses | $2.49B | $2.73B | $2.54B | $2.67B |
| What was left | ||||
| Operating profit | $1.05B | $1.21B | $1.07B | $1.18B |
| Interest on debt | $87.0M | $90.0M | $90.0M | $96.0M |
| Profit before tax | $939.0M | $700.0M | $1.16B | $1.06B |
| Tax | $183.0M | $31.0M | -$176.0M | $155.0M |
| Net profit | $755.0M | $668.0M | $1.34B | $907.0M |
| EBITDA | $1.37B | $1.16B | $1.60B | $1.39B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
Tone of tracked coverage
Boston Scientific left nursing its bottom line after cyberattack
BearishSep 8Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers
BearishSep 8Boston Scientific Warns On Earnings After Cyberattack
BearishSep 8Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
NeutralSep 8Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
BearishSep 8TD Cowen reiterates Boston Scientific stock Buy rating after cyber recovery
Leans bullishSep 8State offers record $40M package to keep Insulet Corp. in state
NeutralSep 8Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
BearishSep 8
Macro
32 macro signals shaping BSX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results